Viatris Other Non-Current Liabilities increased by 3.4% to $2.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.9%, from $1.84B to $2.08B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -4.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.24B | $2.05B | $1.93B | $1.88B | $1.81B | $1.75B | $1.76B | $1.72B | $1.67B | $1.65B | $1.52B | $1.83B | $1.80B | $1.87B | $1.94B | $1.84B | $1.84B | $1.82B | $2.01B | $2.08B |
| QoQ Change | — | -8.4% | -5.8% | -2.5% | -3.7% | -3.8% | +0.7% | -2.1% | -2.6% | -1.6% | -7.9% | +20.3% | -1.6% | +4.1% | +3.7% | -4.9% | -0.5% | -0.7% | +10.5% | +3.4% |
| YoY Change | — | — | — | — | -19.1% | -15.0% | -9.2% | -8.7% | -7.7% | -5.6% | -13.6% | +6.1% | +7.3% | +13.5% | +27.8% | +1.1% | +2.2% | -2.5% | +3.9% | +12.9% |